MultiHance 用於乳房顯影之相關文獻

Grimm LJ, Anderson AL, Baker JA, Johnson KS, Walsh R, Yoon SC, Ghate SV.Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.

AJR Am J Roentgenol. 2015 May;204(5):1120-4. doi: 10.2214/AJR.14.13047.

www.ncbi.nlm.nih.gov/pubmed/25905951

 

Gilbert FJ, van den Bosch HC, Petrillo A, Siegmann K, Heverhagen JT, Panizza P, Gehl HB, Pediconi F, Diekmann F, Peng WJ, Ma L, Sardanelli F, Belli P, Corcione S, Zechmann CM, Faivre-Pierret M, Martincich L. Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer. J Magn Reson Imaging. 2014 May;39(5):1272-86.

www.ncbi.nlm.nih.gov/pubmed/25006633

 

Yi A, Cho N, Im SA, Chang JM, Kim SJ, Moon HG, Han W, Park IA, Noh DY, Moon WK. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.  Radiology. 2013 Sep;268(3):662-72.

www.ncbi.nlm.nih.gov/pubmed/23592770

 

Pediconi F, Kubik-Huch R, Chilla B, Schwenke C, Kinkel K. Intra-individual randomised comparison of gadobutrol 1.0 M versus gadobenate dimeglumine 0.5 M in patients scheduled for preoperative breast MRI. Eur Radiol. 2013 Jan;23(1):84-92.

www.ncbi.nlm.nih.gov/pubmed/22797979

 

Londero V, Zuiani C, Linda A, Girometti R, Bazzocchi M, Sardanelli F High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision. AJR Am J Roentgenol. 2012 Aug;199(2):W240-50.

www.ncbi.nlm.nih.gov/pubmed/22826427

 

Pages EB, Millet I, Hoa D, Doyon FC, Taourel P. Undiagnosed breast cancer at MR imaging: analysis of causes. Radiology. 2012 Jul;264(1):40-50.

www.ncbi.nlm.nih.gov/pubmed/22523324

 

Wang QJ, Wang Y, Xu X, Xiao H, Ma L. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases]. Nan Fang Yi Ke Da Xue Xue Bao

www.ncbi.nlm.nih.gov/pubmed/22200693

 

El Khouli RH, Macura KJ, Kamel IR, Jacobs MA, Bluemke DA. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis. AJR Am J Roentgenol. 2011 Dec;197(6):1498-505

www.ncbi.nlm.nih.gov/pubmed/22109308

 

Carbonaro LA, Pediconi F, Verardi N, Trimboli RM, Calabrese M, Sardanelli F. Breast MRI using a high-relaxivity contrast agent: an overview. AJR Am J Roentgenol. 2011 Apr;196(4):942-55.

www.ncbi.nlm.nih.gov/pubmed/21427349

 

Martincich L, Faivre-Pierret M, Zechmann CM, Corcione S, van den Bosch HC, Peng WJ, Petrillo A, Siegmann KC, Heverhagen JT, Panizza P, Gehl HB, Diekmann F, Pediconi F, Ma L, Gilbert FJ, Sardanelli F, Belli P, Salvatore M, Kreitner KF, Weiss CM, Zuiani C. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial). Radiology. 2011 Feb;258(2):396-408.

www.ncbi.nlm.nih.gov/pubmed/21163915

 

Ei Khouli RH, Jacobs MA, Mezban SD, Huang P, Kamel IR, Macura KJ, Bluemke DA. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology. 2010 Jul;256(1):64-73.

www.ncbi.nlm.nih.gov/pubmed/20574085

 

Carbonaro LA, Verardi N, Di Leo G, Sardanelli F. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement. Invest Radiol. 2010 Mar;45(3):114-20.

www.ncbi.nlm.nih.gov/pubmed/20065856

 

Sardanelli F, Fausto A, Esseridou A, Di Leo G, Kirchin MA. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance. Invest Radiol. 2008 Apr;43(4):236-42.

www.ncbi.nlm.nih.gov/pubmed/18340247

 

Pediconi F1, Catalano C, Occhiato R, Venditti F, Fraioli F, Napoli A, Kirchin MA, Passariello R. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology. 2005 Oct;237(1):45-56. Epub 2005 Aug 26.

www.ncbi.nlm.nih.gov/pubmed/16126926

 

Sardanelli F1, Iozzelli A, Fausto A, Carriero A, Kirchin MA. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology. 2005 Jun;235(3):791-7. Epub 2005 Apr 21.

www.ncbi.nlm.nih.gov/pubmed/15845796

 

Knopp MV1, Bourne MW, Sardanelli F, Wasser MN, Bonomo L, Boetes C, Müller-Schimpfle M, Hall-Craggs MA, Hamm B, Orlacchio A, Bartolozzi C, Kessler M, Fischer U, Schneider G, Oudkerk M, Teh WL, Gehl HB, Salerio I, Pirovano G, La Noce A, Kirchin MA, Spinazzi A. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. AJR Am J Roentgenol. 2003 Sep;181(3):663-76.

www.ncbi.nlm.nih.gov/pubmed/12933457

聯絡我們

普樂可醫藥股份有限公司 地址 : 台北市民生東路一段58號11樓 電話 : (02) 2521-0566
傳真 : (02) 2571-0157
p5418173@ms17.hinet.net